To our knowledge, this study demonstrates for the first time that high SSTR2 expression in HGG is associated with IDH1 mutation which is regarded as the most powerful prognostic marker for a favorable outcome compared to IDH1 wild-type gliomas [18]. Here, IDH1 is linked to glioma.